Expanded Ancillary Supply Kits for Pfizer-BioNTech COVID-19 Vaccines

Jan. 19, 2021

For the Pfizer-BioNTech COVID-19 vaccine, McKesson is now creating mega supply kits to support 1,170 doses – enough for six doses per vial. The ancillary supply kits are shipped separately from the vaccine.

Moderna COVID-19 Vaccine Distribution Delay

Jan. 18, 2021

McKesson learned on Monday, Jan. 18, that certain deliveries of Moderna vaccines shipped on Sunday, Jan. 17, arrived at the sites of administration colder than the low end of the manufacturer’s stated temperature range. McKesson is replacing these vaccines. We also identified the root cause of the issue – some of the gel packs used to maintain appropriate temperatures during shipping were found to be conditioned too cold – and have taken steps to prevent this from occurring in the future.

McKesson also proactively reviewed doses that were slated for shipment on Monday, Jan. 18, and determined that a small percentage of those shipments were also impacted by the gel pack temperature issue. McKesson did not ship those doses and is replacing them within the next 24 hours. McKesson worked directly with the CDC to notify each state awardee that was expecting a shipment about the delay.

McKesson is honored to play a pivotal role in this initiative of unprecedented scale. In this complex distribution program, our goal is that every shipment be received at the administration sites in a timely manner and within the temperature guidelines established by the manufacturer.